Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6756
Source ID: NCT01487798
Associated Drug: Biphasic Human Insulin 30
Title: Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Acronym: REACH
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic human insulin 30|DRUG: biphasic insulin aspart 30
Outcome Measures: Primary: Frequency of hypoglycaemic episodes | Secondary: Frequency of reported severe hypoglycaemic episodes|Overall frequency of nocturnal hypoglycaemia|HbA1c (glycosylated haemoglobin A1c)|Diabetes Treatment Satisfaction Questionaire
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 170
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2002-06
Completion Date: 2003-11
Results First Posted:
Last Update Posted: 2017-01-06
Locations: Novo Nordisk Investigational Site, Bolton, BL1 4QS, United Kingdom|Novo Nordisk Investigational Site, Cardiff, CF14 4XW, United Kingdom|Novo Nordisk Investigational Site, Derby, DE7 1DY, United Kingdom|Novo Nordisk Investigational Site, Dundee, DD1 9SY, United Kingdom|Novo Nordisk Investigational Site, Exeter, EX2 5AX, United Kingdom|Novo Nordisk Investigational Site, Galway, EIRE, United Kingdom|Novo Nordisk Investigational Site, Glasgow, G4 0SF, United Kingdom|Novo Nordisk Investigational Site, Leicester, LE1 5WW, United Kingdom|Novo Nordisk Investigational Site, Liverpool, L7 8XP, United Kingdom|Novo Nordisk Investigational Site, London, NW10 7NS, United Kingdom|Novo Nordisk Investigational Site, London, SE1 7EH, United Kingdom|Novo Nordisk Investigational Site, Newcastle, NE7 7DN, United Kingdom|Novo Nordisk Investigational Site, Nottingham, NG7 2UH, United Kingdom|Novo Nordisk Investigational Site, Sheffield, S5 7AU, United Kingdom|Novo Nordisk Investigational Site, Upton, L49 5PE, United Kingdom|Novo Nordisk Investigational Site, Wirral, Merseyside, CH63 4JY, United Kingdom|Novo Nordisk Investigational Site, York, YO3 7HE, United Kingdom
URL: https://clinicaltrials.gov/show/NCT01487798

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress